Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Frequency depends on your individual health needs
Two of the four patients experienced an improvement in weight and glycaemic control
The most common side effects are gastrointestinal and include nausea, vomiting, diarrhea, constipation, and stomach discomfort
GLP-1 agonists primarily aid in weight loss and cardiovascular protection, while SGLT2 inhibitors provide strong kidney and heart failure benefits
Ozempic is a brand name for semaglutide, available as an FDA-approved injectable or pill medication, prescribed primarily for managing type 2 diabetes
Emerging Research and Clinical Evidence While research in this area is still evolving, early studies show promising results: A review of health records for over 220,000 smokers with type 2 diabetes found that those prescribed semaglutide (a GLP-1 receptor agonist) were less likely to have medical encounters related to smoking compared to patients on other anti-diabetes medications
